Targeting interleukin-1 in the treatment of rheumatoid arthritis

被引：68

作者：

Dayer, JM ^{[1
]}

Bresnihan, B

机构：

[1] Univ Hosp Geneva, Immunol Allergy Div, CH-1211 Geneva 14, Switzerland

[2] St Vincents Univ Hosp, Dublin, Ireland

来源：

ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 03期

关键词：

D O I：

10.1002/art.10168

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：574 / 578

页数：5

共 30 条

[21] Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting
Kastrati, A
Koch, W
Berger, PB
Mehilli, J
Stephenson, K
Neumann, FJ
von Beckerath, N
Böttiger, C
Duff, GW
Schomig, A
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) : 2168 - 2173
[22] Infliximab and methotrexate in the treatment of rheumatoid arthritis
Lipsky, PE
van der Heijde, DMFM
St Clair, EW
Furst, DE
Breedveld, FC
Kalden, JR
Smolen, JS
Weisman, M
Emery, P
Feldmann, M
Harriman, GR
Maini, RN
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) : 1594 - 1602
[23] Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO
[24] 2-W
[25] Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene
Nicklin, MJH
Hughes, DE
Barton, JL
Ure, JM
Duff, GW
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (02) : 303 - 311
[26] PRIEUR AM, 1987, LANCET, V2, P1240
[27] SECKINGER P, 1987, J IMMUNOL, V139, P1546
[28] SECKINGER P, 1990, J IMMUNOL, V145, P4181
[29] Uncoupling of inflammatory and destructive mechanisms in arthritis
van den Berg, WB
[J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2001, 30 (05) : 7 - 16
[30] A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
Weinblatt, ME
Kremer, JM
Bankhurst, AD
Bulpitt, KJ
Fleischmann, RM
Fox, RI
Jackson, CG
Lange, M
Burge, DJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (04) : 253 - 259

← 1 2 3 →